Marijuana for HIV-Related Peripheral Neuropathy

• Status: Completed
• Trial end date: 2005-04-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate whether smoked marijuana reduces pain in people with HIV-related peripheral neuropathy.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Center for Medicinal Cannabis Research

Criteria

INCLUSION CRITERIA:

• HIV positive.

• Be 18 years or older.

• Diagnosis of HIV-related painful neuropathy.

• Stable antiretroviral therapy or no antiretroviral therapy for at least 8 weeks.

• Prior use of marijuana, at least 6 occasions in their lifetime prior to enrollment.

EXCLUSION CRITERIA: (Not allowed)

• Current use of smoked tobacco products.

• Current methadone treatment.

• Use of smoked marijuana within 30 days of enrollment.

• Diagnosis of diabetes mellitus.

• Currently receiving treatment with corticosteroids.

• Use of INH, dapsone or metronidazole within 8 weeks prior to enrollment.

• Severe heart disease, uncontrolled high blood pressure or lung disease.

• Women who are pregnant or breastfeeding.